Nowadays, TREM2 has attracted much attention from researchers in the fields of neurodegenerative diseases, neuroinflammation, immunity, cardiac dysfunction, atherosclerosis, metabolic diseases (such as obesity), and cancer 3, 5-9. This evidence concerns the gene TREM2 and obesity due to melanocortin 4 receptor deficiency.